Clinical Trial Update: The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the impact of neo-adjuvant transarterial chemoinfusion on survival in hepatocellular carcinoma patients undergoing hepatecto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN